Table 1 Demographic data and location of tumours
From: Can p63 serve as a biomarker for giant cell tumor of bone? A Moroccan experience
Case number | Diagnosis | Age | Sex | Location |
|---|---|---|---|---|
1 | osteosarcoma | 34 | F | femur |
2 | osteosarcoma | 40 | F | femur |
3 | osteosarcoma | 19 | M | femur |
4 | osteosarcoma | 19 | M | femur |
5 | osteosarcoma | 12 | F | femur |
6 | osteosarcoma | 14 | F | femur |
7 | osteosarcoma | 23 | M | humerus |
8 | osteosarcoma | 21 | F | humerus |
9 | osteosarcoma | 20 | M | humerus |
10 | osteosarcoma | 25 | M | Tibia |
11 | osteosarcoma | 18 | F | Tibia |
12 | osteosarcoma | 27 | M | mandible |
13 | osteoblastoma | 14 | M | femur |
14 | osteoblastoma | 19 | F | femur |
15 | osteoblastoma | 20 | F | radius |
16 | osteoblastoma | 25 | F | Cuneiform bone |
17 | osteoblastoma | 23 | M | 5th metatarsal bone |
18 | osteoblastoma | 23 | M | astragal |
19 | osteoblastoma | 21 | M | mandible |
20 | osteoblastoma | 57 | M | vertebrae |
21 | GCTOB | 29 | F | femur |
22 | GCTOB | 30 | M | femur |
23 | GCTOB | 21 | F | 5th metacarpal bone |
24 | GCTOB | 21 | F | Fibula |
25 | GCTOB | 40 | F | Tibia |
26 | ABC | 19 | F | Fibula |
27 | ABC | 14 | F | Fibula |
28 | ABC | 16 | M | Femur |
29 | ABC | 13 | F | Tibia |
30 | ABC | 15 | M | 1st metatarsal bone |
31 | OO | 30 | F | femur |
32 | OO | 28 | M | femur |
33 | OO | 24 | M | astragal |
34 | OO | 24 | M | Fibula |
35 | CGCG | 9 | M | mandible |
36 | CGCG | 15 | M | mandible |
37 | CGCG | 48 | F | Maxilla |
38 | CGCG | 53 | F | Maxilla |
39 | NOF | 16 | F | Tibia |
40 | NOF | 19 | M | Tibia |
41 | NOF | 16 | F | Tibia |
42 | NOF | 8 | M | femur |
43 | CMF | 23 | M | Toe |
44 | CMF | 33 | M | Tibia |
45 | CMF | 59 | F | Sphenoid bone |
46 | FD | 19 | M | Femur |
47 | chondroblastoma | 23 | M | calcaneus |
48 | LCH | 7 | M | Ilium |